Synthesis and structure-activity relationships of a novel and selective bone morphogenetic protein receptor (BMP) inhibitor derived from the pyrazolo[1.5-a]pyrimidine scaffold of Dorsomorphin: The discovery of ML347 as an ALK2 versus ALK3 selective MLPCN probe

Darren W. Engers, Audrey Y. Frist, Craig W. Lindsley, Charles C. Hong, Corey R. Hopkins

Research output: Contribution to journalArticle

47 Scopus citations

Fingerprint Dive into the research topics of 'Synthesis and structure-activity relationships of a novel and selective bone morphogenetic protein receptor (BMP) inhibitor derived from the pyrazolo[1.5-a]pyrimidine scaffold of Dorsomorphin: The discovery of ML347 as an ALK2 versus ALK3 selective MLPCN probe'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds